Lihua E. Budde, Won-Seog Kim, Eduardo M. Rego, Danielle Leão Cordeiro de Farias, Adam J. Olszewski, Nikesh Shah, Shen Yin, Hao Wu, Iris To, Wahib S. Ead, Joan Ashby, Martin Janousek, Song Pham, Jue Wang, Antonia Kwan, Connie L. Batlevi, Michael C. Wei, Astrid Pavlovsky, Dorotea Fantl, Carolina Valeria Mahuad, Maria Custidiano, Laura Maria Fogliatto, Eduardo Rego, Diego Villa Cle, Joao Farias, Danielle Farias, John Kuruvilla, Stephane Doucet, Mark Bosch, Gwynivere Davies, Huilai Zhang, Xiaoxi Zhou, Huangming Hong, Li Yu, Jianzhen Shen, Yanyan Liu, Hongyan Tong, Zhiming Li, Itai Levi, Uri Abadi, Irit Avivi, Keiko Aizawa, Dai Maruyama, Yoshiaki Ogawa, Takahiro Kumode, Noriko Fukuhara, Motoko Yamaguchi, Hideki Goto, Koji Kato, Tadakazu Kondo, Tae Min Kim, Won Seog Kim, Ho-jin Shin, Young-Woo Jeon, Jin Seok Kim, Myungwon Lee, Luis Rubalcava, David Gomez Almaguer, Gladys Patricia Agreda Vasquez, Juan Manuel Perez Zuniga, Gilberto Barranco Lampon, Samar Issa, Cesar Samanez, Luz Ventura, Archrob Khuhapinant, Kitsada Wudhikarn, Lalita Norasetthada, Chinadol Wanitpongpun, Mehmet Turgut, Senem Maral, Inci Alacacioglu, Zafer Gulbas, Muhit Ozcan, Ashraf Aziz, Elizabeth Budde, Adam Olszewski, Jason Westin, Mark Fesler, Ruemu Birhiray, Nihal Abdulla, Steven Liu, Bei Hu, Zaw Myint, Boone Goodgame, Izidore Lossos, Jason Salganick. "Mosunetuzumab Plus Polatuzumab Vedotin in Transplant-Ineligible Refractory/Relapsed Large B-Cell Lymphoma: Primary Results of the Phase III SUNMO Trial." Journal of Clinical Oncology, 2025. doi:10.1200/jco-25-01957